References

Reference list

1. Cianferoni A et al. Food avoidance strategies in eosinophilic oesophagitis. Clin Exp Allergy. 2019;9;269-284.

2. Navarro P et al. Systematic review with meta-analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther. 2019;49:1116-1125.

3. Hruz P. Epidemiology of Eosinophilic Esophagitis. Dig Dis 2014.

4. Attwood SEA et al. Esophageal Eosinophilia with Dysphagia A Distinct Clinicopathologic Syndrome. Digestive Disease and Sciences 1993;38(1):109-116.

5. Rank et al Gastroenterol 2020;158:1789–1810. 

6. Lucendo A et al. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial. Gastroenterology 2019.

7. Lucendo A et al. Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients with Symptomatic Esophageal Eosinophilia: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology 2016;14:13–22.

8. Durban R et al. Nutritional Care of the Patient with Eosinophilic Esophagitis. Practical Gastroenterology, APRIL 2018.

9. Warners M J et al. Elemental diet decreases inflammation and improves symptoms in adult eosinophilic oesophagitis patients. Aliment Pharmacol Therapeutics 2017;45:777-787.

10. Philpott et al Aliment Pharmacol Ther 2016; 43: 985–993.

11. Moawad F J et al. Metaanalysis, the safety and efficacy of dilation in eosinophilic oesophagitis. Aliment Pharmacol Ther 2013;38:713-720.

12. Nhu Q et al. New Developments in the Diagnosis and Treatment of Eosinophilic Esophagitis. Curr Treat Options Gastroenterol. 2019 March;17(1):48-62.